Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell World Chess (CHSS) by Steve Moore in ShareProphets
- Avoid Trifast (TRI) by Steve Moore in ShareProphets
- Avoid The Magnum Ice Cream Company (MICC) by Steve Moore in ShareProphets
- Buy Relx plc (REL) by Bank of America
- Buy South32 Limited (DI) (S32) by UBS
- Buy Weir Group (WEIR) by UBS
- Buy Relx plc (REL) by UBS
- Avoid Iomart Group (IOM) by Steve Moore in ShareProphets
- Buy Halma (HLMA) by Goldman Sachs
- Sell Ashmore Group (ASHM) by Deutsche Bank
- Hold Mondi (MNDI) by Deutsche Bank
- Hold Schroders (SDR) by Deutsche Bank
- Buy Relx plc (REL) by Deutsche Bank
- Buy Morgan Sindall Group (MGNS) by Deutsche Bank
- Hold GSK (GSK) by Deutsche Bank
- Overweight Unilever (ULVR) by Barclays
- Buy Morgan Sindall Group (MGNS) by Berenberg
- Outperform Rathbones Group (RAT) by RBC Capital
- Overweight Relx plc (REL) by Barclays
- Outperform Relx plc (REL) by Bernstein
Syncona Limited NPV (SYNC) Share Price
Financial Services Sector
NOTE: This is based on 29 open tips for Syncona Limited NPV (SYNC)
| Latest Bid : 98.90p | Latest Ask : 100.40p |
| High Today : 101.00p | Low Today : 98.80p |
| This Years High : 102.60p | This Years Low : 79.70p |
| Volume : 219,678 | MKT Cap : £616.42M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Syncona Limited NPV (SYNC) Overview
Syncona Limited is a Guernsey-based closed-ended investment company. The Company is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Company's investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).Syncona Limited NPV (SYNC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | William Kay | Premium Only | 2023-06-16 00:05:00 16/06/2023 | 36.36% |
| Buy | Sabah Meddings | Premium Only | 2022-02-13 11:30:00 13/02/2022 | -52.62% |
| Long Term Buy | Richard Evans | Premium Only | 2022-01-06 07:50:00 06/01/2022 | -51.48% |
| Buy | Peel Hunt | Premium Only | 2021-11-04 10:11:00 04/11/2021 | -45.06% |
| Hold | Daniel Grote | Premium Only | 2021-07-15 07:45:00 15/07/2021 | -45.07% |
Syncona Limited NPV (SYNC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 98.90p | Latest Ask : 100.40p |
| High Today : 101.00p | Low Today : 98.80p |
| This Years High : 102.60p | This Years Low : 79.70p |
| Volume : 219,678 | MKT Cap : £616.42M |
Syncona Limited NPV Overview
Syncona Limited is a Guernsey-based closed-ended investment company. The Company is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Company's investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Syncona Limited NPV Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | William Kay | Premium Only | 2023-06-16 00:05:00 16/06/2023 | 36.36% |
| Buy | Sabah Meddings | Premium Only | 2022-02-13 11:30:00 13/02/2022 | -52.62% |
| Long Term Buy | Richard Evans | Premium Only | 2022-01-06 07:50:00 06/01/2022 | -51.48% |
| Buy | Peel Hunt | Premium Only | 2021-11-04 10:11:00 04/11/2021 | -45.06% |
| Hold | Daniel Grote | Premium Only | 2021-07-15 07:45:00 15/07/2021 | -45.07% |